Related Experiment Video
Updated: May 17, 2026
04:04
Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
HCT survival in ADA-SCID: what's the buzz?
Sanny K Chan1, William T Shearer
1Baylor College of Medicine, USA.
Blood
|October 27, 2012
Abstract:
In this issue of Blood, Hassan et al have turned the spotlight on hematopoietic stem cell transplantation (HCT) of adenosine deaminase (ADA)-deficient severe combined immunodeficiency (SCID). They opened up the curtain of beliefs on this therapy that enables facts to be separated from fiction.